Chris Bulman Inc Ocugen, Inc. Put Options Transaction History
Chris Bulman Inc
- $147 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
113Shares Held
67.4MCall Options Held
516KPut Options Held
272K-
Black Rock Inc. New York, NY17.9MShares$18.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$17.3 Million0.0% of portfolio
-
State Street Corp Boston, MA14.8MShares$15.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$6.4 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL2.18MShares$2.22 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $221M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...